Newborn and infant heart transplantation

Area of Science:

• Pediatric cardiology
• Transplantation immunology
• Congenital heart disease surgery

Background:

• Neonatal heart transplantation for hypoplastic left heart syndrome has advanced over the past decade.
• Infants represent a growing proportion of pediatric heart transplant recipients, yet survival rates are lower compared to older children.
• Key challenges include limited donor organ availability, complex pre- and post-transplant management, and advancements in alternative palliative surgical options.

Purpose of the Study:

• To review current challenges and advancements in neonatal heart transplantation.
• To highlight recent findings on donor availability, waiting times, and post-transplant outcomes.
• To discuss strategies for improving infant heart transplant success, including immunologic tolerance and xenotransplantation.

Main Methods:

• Review of recent literature on pediatric heart transplantation outcomes.
• Analysis of data regarding donor availability and waiting times for infant recipients.
• Examination of laboratory investigations into immunologic tolerance and xenotransplantation.

Main Results:

• Survival rates for neonates and infants undergoing heart transplantation remain inferior to those in older pediatric populations.
• Recent research provides insights into donor organ availability, transplant waiting times, and outcomes.
• Ongoing laboratory studies explore methods for inducing immunologic tolerance and the potential of xenotransplantation.

Conclusions:

• Improving survival in infant heart transplantation requires addressing donor limitations and optimizing management strategies.
• Further research into immunologic tolerance and alternative approaches like xenotransplantation is crucial for advancing the field.
• Pediatric cardiologists face unique challenges in infant heart transplantation, necessitating continued innovation and investigation.